News: Research
Read the latest news from the College of Natural Sciences at The University of Texas at Austin
Department of Molecular Biosciences
New Insights Could Lead to Crops Adapted to a Warming World
A new study offers hope that breeders will be able to develop crops that can tolerate higher temperatures while also maintaining high yield

UT News
First Glimpse of Brains Retrieving Mistaken Memories Observed
Scientists have observed for the first time what it looks like in the key memory region of the brain when a mistake is made during...

Xue-Xin Wei Asks Basic Questions about the Nature of Intelligence
Learn more about Xue-Xin Wei's decision to join UT Austin's Department of Neuroscience as an assistant professor and his contributions to the field.

UT News
Fight Against Antibiotic-Resistant Bacteria Has a Glowing New Weapon
In the perpetual arms races between bacteria and human-made antibiotics, there is a new tool to give human medicine the edge.

UT News
Sheltering People With COVID-19 Experiencing Homelessness Curbs Spread
A new study provides public health planning authorities with a method of calculating the number of COVID-19 isolation beds they would need for people experiencing...

Astronomers Disprove Planet Orbiting Nearby Barnard’s Star
An international team that included Michael Endl and Bill Cochran discovered what was thought to an exoplanet was not one.

Department of Molecular Biosciences
'Last Resort' Antibiotic Pops Bacteria Like Balloons
A new study reveals that colistin, a last resort antibiotic “punches holes in bacteria, causing them to pop like balloons.”

Discovery about Brain Cells that Promote Healing from Strokes Offers Treatment Insights
A type of cell once thought to hinder recovery in stroke patients may actually promote the healing process.

Department of Molecular Biosciences
Our Immune Systems Blanket the SARS-CoV-2 Spike Protein with Antibodies
Most antibodies against SARS-CoV-2 circulating in the blood target areas of the viral spike protein outside the receptor binding domain, or RBD

Department of Molecular Biosciences
Hepatitis C Drugs Boost Remdesivir’s Antiviral Activity Against COVID-19
Four drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the coronavirus in cell cultures.
